Nexien Biopharma, Inc.
NXEN
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 10-Q |
5/14/2025 |
Q3 |
2025 |
3/31/2025 |
SEC |
view |
|
| 10-Q |
2/14/2025 |
Q2 |
2025 |
12/31/2024 |
SEC |
view |
|
| 10-Q |
11/18/2024 |
Q1 |
2025 |
9/30/2024 |
SEC |
view |
|
| 10-K |
10/22/2024 |
Q4 |
2024 |
6/30/2024 |
SEC |
view |
|
| 10-Q |
5/15/2024 |
Q3 |
2024 |
3/31/2024 |
SEC |
view |
|
| 10-Q |
2/20/2024 |
Q2 |
2024 |
12/31/2023 |
SEC |
view |
|
| 10-Q |
11/14/2023 |
Q1 |
2024 |
9/30/2023 |
SEC |
view |
|
| 10-K |
9/28/2023 |
Q4 |
2023 |
6/30/2023 |
SEC |
view |
|
| 10-Q |
5/17/2023 |
Q3 |
2023 |
3/31/2023 |
SEC |
view |
|
| 10-Q |
2/8/2023 |
Q2 |
2023 |
12/31/2022 |
SEC |
view |
|
| 10-Q |
11/9/2022 |
Q1 |
2023 |
9/30/2022 |
SEC |
view |
|
| 10-K |
9/28/2022 |
Q4 |
2022 |
6/30/2022 |
SEC |
view |
|
| 10-Q |
5/12/2022 |
Q3 |
2022 |
3/31/2022 |
SEC |
view |
|
| 10-Q |
2/8/2022 |
Q2 |
2022 |
12/31/2021 |
SEC |
view |
|
| 10-Q |
11/22/2021 |
Q1 |
2022 |
9/30/2021 |
SEC |
view |
|
| 10-K |
10/12/2021 |
Q4 |
2021 |
6/30/2021 |
SEC |
view |
|
| 10-Q |
5/5/2021 |
Q3 |
2021 |
3/31/2021 |
SEC |
view |
|
| 10-Q |
2/11/2021 |
Q2 |
2021 |
12/31/2020 |
SEC |
view |
|
| 10-Q |
11/10/2020 |
Q1 |
2021 |
9/30/2020 |
SEC |
view |
|
| 10-K |
9/28/2020 |
Q4 |
2020 |
6/30/2020 |
SEC |
view |
|
| 10-Q |
5/14/2020 |
Q3 |
2020 |
3/31/2020 |
SEC |
view |
|
| 10-Q |
2/12/2020 |
Q2 |
2020 |
12/31/2019 |
SEC |
view |
|
| 10-Q |
11/12/2019 |
Q1 |
2020 |
9/30/2019 |
SEC |
view |
|
| 10-K |
9/30/2019 |
Q4 |
2019 |
6/30/2019 |
SEC |
view |
|
| 10-Q |
5/14/2019 |
Q3 |
2019 |
3/31/2019 |
SEC |
view |
|
| 10-Q |
2/14/2019 |
Q2 |
2019 |
12/31/2018 |
SEC |
view |
|
| 10-Q |
11/14/2018 |
Q1 |
2019 |
9/30/2018 |
SEC |
view |
|
| 10-K |
9/28/2018 |
Q4 |
2018 |
6/30/2018 |
SEC |
view |
|
| S-1/A |
6/19/2018 |
Q3 |
2018 |
3/31/2018 |
SEC |
view |
|
| S-1/A |
6/11/2018 |
Q3 |
2018 |
3/31/2018 |
SEC |
view |
|
| S-1 |
6/7/2018 |
Q3 |
2018 |
3/31/2018 |
SEC |
view |
|
| 10-Q |
5/15/2018 |
Q3 |
2018 |
3/31/2018 |
SEC |
view |
|
| 10-Q |
2/14/2018 |
Q2 |
2018 |
12/31/2017 |
SEC |
view |
|
| 10-Q |
11/3/2017 |
Q1 |
2018 |
9/30/2017 |
SEC |
view |
|
| 10-K |
7/31/2017 |
Q4 |
2017 |
6/30/2017 |
SEC |
view |
|
| 10-Q |
5/4/2017 |
Q3 |
2017 |
3/31/2017 |
SEC |
view |
|
| 10-Q |
2/6/2017 |
Q2 |
2017 |
12/31/2016 |
SEC |
view |
|
| 10-Q |
10/19/2016 |
Q1 |
2017 |
9/30/2016 |
SEC |
view |
|
| 10-K |
9/28/2016 |
Q4 |
2016 |
6/30/2016 |
SEC |
view |
|
| 10-Q |
4/13/2016 |
Q3 |
2016 |
3/31/2016 |
SEC |
view |
|
| 10-Q |
2/4/2016 |
Q2 |
2016 |
12/31/2015 |
SEC |
view |
|
| 10-Q |
10/14/2015 |
Q1 |
2016 |
9/30/2015 |
SEC |
view |
|
| 10-K |
9/15/2015 |
Q4 |
2015 |
6/30/2015 |
SEC |
view |
|
| 10-Q |
5/6/2015 |
Q3 |
2015 |
3/31/2015 |
SEC |
view |
|
| 10-Q |
2/13/2015 |
Q2 |
2015 |
12/31/2014 |
SEC |
view |
|